Jennifer Chow from CHM did a very slick presentation on their CAR-T pipeline at the ASX Small/Mid Cap conference yesterday. CHM marketing is so good that even the board reads well. Only time will tell. If nothing else I suspect that this may have raised interest in cell therapeutics. Their story has a similar feel, phase 1, planning a basket trial, licensing in from Penn. PTX was set up for a breakout on the charts and I would not be surprised if increased CAR-T awareness gave that break a bit of a boost.
Jennifer Chow from CHM did a very slick presentation on their...
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.85M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.7¢ | 4.6¢ | $13.84K | 300.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 58711 | 4.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.7¢ | 184472 | 6 |
View Market Depth
| Last trade - 16.10pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
4.6¢ |
Change
0.000 ( 2.13 %) |
||||
| Open | High | Low | Volume | ||
| 4.6¢ | 4.7¢ | 4.6¢ | 135240 | ||
| Last updated 15.42pm 04/06/2024 ? | |||||
| PTX (ASX) Chart |